Tags |
|
|
Links |
|
|
Full of Articles - FDA Lifts Silicone Gel Breast Implant Restrictions
The Food and drug Administration has decided to reverse the 1992 ruling and lift the 14-year ban on the use of silicone breast implants in the United states. Two California-based companies, Mentor a
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
nd Allergan, have been approved to manufacture and sell what experts say is a newly designed and safer silicone implant.
Dr. Daniel G. Schultz, director of the F.D.A.’s Center for Devices and Radio
Dr. Daniel G. Schultz, director of the F.D.A.’s Center for Devices and Radio
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
logical Health, said that the F.D.A.’s review of company-sponsored studies on silicone implants, as well as long-term use of the implants around the world, was enough to approve the use of the impla
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
nts in the best interest of American women. Dr. Schultz cautioned however, that no device is completely foolproof and some implants may need to be replaced eventually due to leaks or ruptures.
“Wom
“Wom
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
en should know that breast implants are not lifetime devices,” he told reporters over the phone last night. “Women having these procedures done need to be prepared for the fact that there is a likel
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
ihood they will require additional surgery,” he added.
He also recommended regular M.R.I. scans to monitor for signs of silent rupture, which can occur without the woman’s knowledge and lead to sil
He also recommended regular M.R.I. scans to monitor for signs of silent rupture, which can occur without the woman’s knowledge and lead to sil
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
icone in the bloodstream among other complications. Schultz suggested the first test be conducted after three years of use. Due to the cosmetic nature of most implant procedures, it is not yet clear
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
whether those diagnostic scans would be covered by medical insurance.
Dr. Scott L. Spear, chief of plastic surgery at Georgetown University, who conducted research for Irvine California-based Aller
Dr. Scott L. Spear, chief of plastic surgery at Georgetown University, who conducted research for Irvine California-based Aller
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
gan,, said the devices are greatly improved since the early 1990’s.
“The shells themselves are made of different materials, a barrier shell, that is relatively much more impermeable,” he described.
“The shells themselves are made of different materials, a barrier shell, that is relatively much more impermeable,” he described.
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
“The shells are thicker than in ‘91, much thicker than they were in earlier generations. The material inside is more cohesive, the stuff tends to stick together.”
Some health experts remain unconv
Some health experts remain unconv
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
inced, and criticized the agency’s decision to lift the ban.
Dr. Sidney Wolfe, chief of Public Citizen’s Health Research Group, which led the charge to ban the silicone enhancers in the 80’s due to
Dr. Sidney Wolfe, chief of Public Citizen’s Health Research Group, which led the charge to ban the silicone enhancers in the 80’s due to
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
concerns over cancer and other diseases, called the implants “the most defective medical device ever approved by the F.D.A.
Amy Allina, program director at the National Women’s Health Network, als
Amy Allina, program director at the National Women’s Health Network, als
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
o sharply disapproved of the decision, stating the agency gave the implants the green light despite the manufacturers’ inability to answer basic safety questions, such as exactly how long implants w
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ould last without rupturing, and whether there would be adverse health effects if the silicone leaked and traveled to other areas of the body.
“We have been looking at this data continuously for th
“We have been looking at this data continuously for th
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
last 10 years. We have been watching as data had been collected, we have been watching as data has accumulated,” said Schultz. “We believe that from a scientific standpoint, the decision that we’re
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
making tonight is, in fact, in the best interest of American women.”
He added the agency would require the companies to conduct ongoing post-surgery studies involving a total of 80,000 subjects to
He added the agency would require the companies to conduct ongoing post-surgery studies involving a total of 80,000 subjects to
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
continue monitoring the safety of the gel implants. He said the F.D.A. is interested in information relating to rates of rupture, cancer and autoimmune diseases and effects of the implants on repro
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
duction which would enable the agency to evaluate concerns about the implants in a large number of women.
Schultz also stated that the implants would be available to all women for reconstruction fr
Schultz also stated that the implants would be available to all women for reconstruction fr
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
om breast cancer trauma or to those affected by development disorders of the chest, but that women who simply wanted a cosmetic enhancement would be required to be over the age of 22. Schultz said t
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
his regulation was put in place to ensure that patients would be fully developed in the breast before having the implant surgery.
Canada lifted it’s ban on silicone implants in October of this year
Canada lifted it’s ban on silicone implants in October of this year
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.fullofarticles.org.ua/article/233508/fullofarticles-FDA-Lifts-Silicone-Gel-Breast-Implant-Restrictions.html">FDA Lifts Silicone Gel Breast Implant Restrictions</a>
BB link (for phorums):
[url=http://www.fullofarticles.org.ua/article/233508/fullofarticles-FDA-Lifts-Silicone-Gel-Breast-Implant-Restrictions.html]FDA Lifts Silicone Gel Breast Implant Restrictions[/url]
Related Articles:
Bookmark it:
|